• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Surgery Partners Inc.

    2/5/26 1:40:12 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care
    Get the next $SGRY alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 6)


    SURGERY PARTNERS INC

    (Name of Issuer)


    COMMON STOCK

    (Title of Class of Securities)


    86881A100

    (CUSIP Number)


    12/31/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    86881A100


    1Names of Reporting Persons

    FMR LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    6,536,092.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    6,537,015.77
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    6,537,015.77
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.1 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    CUSIP No.
    86881A100


    1Names of Reporting Persons

    Abigail P. Johnson
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    6,537,015.77
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    6,537,015.77
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.1 %
    12Type of Reporting Person (See Instructions)

    IN


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    SURGERY PARTNERS INC
    (b)Address of issuer's principal executive offices:

    310 SEVEN SPRINGS WAY,SUITE 500,BRENTWOOD,TN,USA,37027
    Item 2. 
    (a)Name of person filing:

    FMR LLC
    (b)Address or principal business office or, if none, residence:

    245 Summer Street, Boston, Massachusetts 02210
    (c)Citizenship:

    Not applicable
    (d)Title of class of securities:

    COMMON STOCK
    (e)CUSIP No.:

    86881A100
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    6537015.77
    (b)Percent of class:

    5.1  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    Please see the responses to Items 5 and 6 on the cover page.

     (ii) Shared power to vote or to direct the vote:

    0.00

     (iii) Sole power to dispose or to direct the disposition of:

    6537015.77

     (iv) Shared power to dispose or to direct the disposition of:

    0.00

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Not Applicable
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of SURGERY PARTNERS INC. No one other person's interest in the COMMON STOCK of SURGERY PARTNERS INC is more than five percent of the total outstanding COMMON STOCK.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.


    See attached Exhibit 99.
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    FMR LLC
     
    Signature:Stephanie J. Brown
    Name/Title:Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
    Date:02/04/2026
     
    Abigail P. Johnson
     
    Signature:Stephanie J. Brown
    Name/Title:Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson**
    Date:02/04/2026

    Comments accompanying signature:  * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.
    Exhibit Information

    Please see Exhibit 99 for 13d-1(k) (1) agreement.

    Get the next $SGRY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SGRY

    DatePrice TargetRatingAnalyst
    9/18/2025$27.00Neutral
    Analyst
    7/28/2025$28.00Buy
    BofA Securities
    12/16/2024$30.00Buy
    BofA Securities
    10/14/2024$38.00Buy
    UBS
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    6/28/2024$31.00Outperform
    Macquarie
    3/6/2024$35.00Equal Weight
    Barclays
    11/14/2023$39.00 → $35.00Market Perform → Outperform
    TD Cowen
    More analyst ratings

    $SGRY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Evans Jason Eric sold $158,061 worth of shares (11,462 units at $13.79) and was granted 278,106 shares, increasing direct ownership by 40% to 940,786 units (SEC Form 4)

    4 - Surgery Partners, Inc. (0001638833) (Issuer)

    3/9/26 7:33:25 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Chief Admin & Dev Officer Baldock Jennifer was granted 106,307 shares and sold $138,123 worth of shares (10,082 units at $13.70), increasing direct ownership by 41% to 332,272 units (SEC Form 4)

    4 - Surgery Partners, Inc. (0001638833) (Issuer)

    3/9/26 7:33:13 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Chief Financial Officer Doherty David T sold $201,704 worth of shares (14,574 units at $13.84) and was granted 141,743 shares, increasing direct ownership by 123% to 230,546 units (SEC Form 4)

    4 - Surgery Partners, Inc. (0001638833) (Issuer)

    3/9/26 7:33:19 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    $SGRY
    SEC Filings

    View All

    SEC Form 10-K filed by Surgery Partners Inc.

    10-K - Surgery Partners, Inc. (0001638833) (Filer)

    3/2/26 5:11:59 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Surgery Partners Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Surgery Partners, Inc. (0001638833) (Filer)

    3/2/26 4:55:31 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Surgery Partners Inc.

    SCHEDULE 13G/A - Surgery Partners, Inc. (0001638833) (Subject)

    2/17/26 5:17:09 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    $SGRY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst resumed coverage on Surgery Partners with a new price target

    Analyst resumed coverage of Surgery Partners with a rating of Neutral and set a new price target of $27.00

    9/18/25 8:45:00 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    BofA Securities resumed coverage on Surgery Partners with a new price target

    BofA Securities resumed coverage of Surgery Partners with a rating of Buy and set a new price target of $28.00

    7/28/25 9:00:02 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    BofA Securities initiated coverage on Surgery Partners with a new price target

    BofA Securities initiated coverage of Surgery Partners with a rating of Buy and set a new price target of $30.00

    12/16/24 6:50:04 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    $SGRY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Surgery Partners, Inc. Names Lloyd Dean to Board of Directors

    BRENTWOOD, Tenn., March 12, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company") recently announced that Lloyd Dean has been appointed to serve as an independent director on its Board of Directors. Mr. Dean is the former Chief Executive Officer of CommonSpirit Health, one of the largest nonprofit health systems in the United States, with 142 hospitals, over 1,000 care sites, 25,000 physicians, and 150,000 employees across 21 states. From 2019 to 2022, he led the formation and integration of CommonSpirit, advancing clinical quality, operational performance, and community health initiatives at national scale. Prior to CommonSpirit, Mr. Dean ser

    3/12/26 6:12:07 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Ortelius Delivers Open Letter to Surgery Partners Stockholders

    Surgery Board and Management Team Have Presided Over the Vast Destruction of Value and Must Be Held Accountable Letter Outlines Multiple Paths to Building and Unlocking Intrinsic Value for Stockholders Divestiture of Surgical Hospitals Should Generate Billions of Dollars in Asset Sales, Enabling Stock Repurchase and Balance Sheet Deleveraging Ortelius Advisors, L.P. today issued the following open letter to stockholders of Surgery Partners, Inc. (NASDAQ:SGRY). March 10, 2026 Fellow Stockholders, Ortelius Advisors, L.P. ("Ortelius" or "we") believes that Surgery Partners, Inc. ("Surgery" or the "Company") has significant upside potential, based on its high-quality assets, favorab

    3/10/26 11:00:00 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Surgery Partners, Inc. to Present at Upcoming Investor Conference

    BRENTWOOD, Tenn., March 09, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), is scheduled to meet with investors at the Barclays 28th Annual Global Healthcare Conference, including a presentation on Tuesday, March 10, 2026, at 2:30 p.m. (Eastern Time). Interested investors and other parties may listen to a simultaneous webcast of the event through the investor relations section of the company's website at www.surgerypartners.com. The replay will also be available on this same website for a limited time following the call. To learn more about Surgery Partners, please visit the Company's website at www.surgerypartners.com. Surgery Partner

    3/9/26 12:04:19 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    $SGRY
    Leadership Updates

    Live Leadership Updates

    View All

    Surgery Partners, Inc. Names Lloyd Dean to Board of Directors

    BRENTWOOD, Tenn., March 12, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company") recently announced that Lloyd Dean has been appointed to serve as an independent director on its Board of Directors. Mr. Dean is the former Chief Executive Officer of CommonSpirit Health, one of the largest nonprofit health systems in the United States, with 142 hospitals, over 1,000 care sites, 25,000 physicians, and 150,000 employees across 21 states. From 2019 to 2022, he led the formation and integration of CommonSpirit, advancing clinical quality, operational performance, and community health initiatives at national scale. Prior to CommonSpirit, Mr. Dean ser

    3/12/26 6:12:07 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Surgery Partners, Inc. Names Laura L. Forese, MD to Board of Directors

    BRENTWOOD, Tenn., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company") today announced that Dr. Laura L. Forese has been appointed to serve as an independent director on its Board of Directors. Dr. Forese's appointment, which is effective January 10, 2025, will increase the size of Surgery Partners' Board to eleven members. Dr. Forese joins the Surgery Partners Board with extensive healthcare experience. Her career in healthcare administration spans over 40 years, most recently serving as an executive vice president and chief operating officer for New York-Presbyterian, one of the nation's most comprehensive, integrated academic heal

    1/13/25 5:00:24 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Teladoc Health Appoints Leading Healthcare and Hospitals Executive Eric Evans to Board of Directors

    PURCHASE, NY, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today appointed Eric Evans to the company's board of directors. Mr. Evans, currently chief executive officer and director of Brentwood, TN-based Surgery Partners, Inc. (NASDAQ:SGRY), is a recognized healthcare and hospital executive with significant experience leading complex organizations operating at the intersection of care and technology. Mr. Evans joins the board following the retirement of Senator William Frist, M.D. earlier this year, and will serve on the board's compensation committee. David B. Snow, Jr., non-executive Chairman of the company's board,

    9/20/23 8:05:00 AM ET
    $SGRY
    $TDOC
    Hospital/Nursing Management
    Health Care
    Medical/Nursing Services

    $SGRY
    Financials

    Live finance-specific insights

    View All

    Ortelius Delivers Open Letter to Surgery Partners Stockholders

    Surgery Board and Management Team Have Presided Over the Vast Destruction of Value and Must Be Held Accountable Letter Outlines Multiple Paths to Building and Unlocking Intrinsic Value for Stockholders Divestiture of Surgical Hospitals Should Generate Billions of Dollars in Asset Sales, Enabling Stock Repurchase and Balance Sheet Deleveraging Ortelius Advisors, L.P. today issued the following open letter to stockholders of Surgery Partners, Inc. (NASDAQ:SGRY). March 10, 2026 Fellow Stockholders, Ortelius Advisors, L.P. ("Ortelius" or "we") believes that Surgery Partners, Inc. ("Surgery" or the "Company") has significant upside potential, based on its high-quality assets, favorab

    3/10/26 11:00:00 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2025 Results; Sets 2026 Guidance; Announces Share Repurchase Program

    BRENTWOOD, Tenn., March 02, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Full Year 2025 Financial Highlights (All comparisons are year-over-year unless otherwise noted) Revenue increased 2.4% for the fourth quarter and 6.2% for the full year Same-facility revenues increased 3.5% for the fourth quarter and 4.9% for the full year Surgical cases decreased 2.1% for the fourth quarter and increased 2.0% for the full year Same-facility cases increased 1.3% for the fourth

    3/2/26 4:05:00 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Surgery Partners, Inc. Announces Fourth Quarter 2025 Earnings Release Date and Conference Call Details

    BRENTWOOD, Tenn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2025 results after market close on Monday, March 2, 2026, to be followed by a conference call on Tuesday, March 3, 2026 at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until March 17, 2026): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13758

    2/24/26 1:49:54 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    $SGRY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Surgery Partners Inc.

    SC 13G/A - Surgery Partners, Inc. (0001638833) (Subject)

    11/8/24 10:46:38 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by Surgery Partners Inc.

    SC 13G - Surgery Partners, Inc. (0001638833) (Subject)

    10/24/24 2:02:10 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G/A filed by Surgery Partners Inc. (Amendment)

    SC 13G/A - Surgery Partners, Inc. (0001638833) (Subject)

    2/13/24 5:15:54 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care